Herein, we demonstrated that AS101 downregulates heparanase through the AKT signaling pathway in murine breast cancer and colon carcinoma models (widely used for their highly metastatic properties), and it exhibits significant inhibition of tumor metastasis. Here, AKT1 is linked to neoplasm.